3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oxetan-3-ols as 1,2-bis-Electrophiles in a Brønsted-Acid-Catalyzed Synthesis of 1,4-Dioxanes

      rapid-communication

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Annulations that combine diacceptors with bis-nucleophiles are uncommon. Here, we report the synthesis of 1,4-dioxanes from 3-aryloxetan-3-ols, as 1,2-bis-electrophiles and 1,2-diols. Brønsted acid Tf 2NH catalyzes both the selective activation of the oxetanol, to form an oxetane carbocation that reacts with the diol, and intramolecular ring opening of the oxetane. High regio- and diastereoselectivity are achieved with unsymmetrical diols. The substituted dioxanes and fused bicyclic products present interesting motifs for drug discovery and can be further functionalized.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Escape from flatland: increasing saturation as an approach to improving clinical success.

          The medicinal chemistry community has become increasingly aware of the value of tracking calculated physical properties such as molecular weight, topological polar surface area, rotatable bonds, and hydrogen bond donors and acceptors. We hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose molecules to fail by steering discovery efforts toward achiral, aromatic compounds. We have proposed two simple and interpretable measures of the complexity of molecules prepared as potential drug candidates. The first is carbon bond saturation as defined by fraction sp(3) (Fsp(3)) where Fsp(3) = (number of sp(3) hybridized carbons/total carbon count). The second is simply whether a chiral carbon exists in the molecule. We demonstrate that both complexity (as measured by Fsp(3)) and the presence of chiral centers correlate with success as compounds transition from discovery, through clinical testing, to drugs. In an attempt to explain these observations, we further demonstrate that saturation correlates with solubility, an experimental physical property important to success in the drug discovery setting.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Oxetanes in drug discovery: structural and synthetic insights.

            An oxetane can trigger profound changes in aqueous solubility, lipophilicity, metabolic stability, and conformational preference when replacing commonly employed functionalities such as gem-dimethyl or carbonyl groups. The magnitude of these changes depends on the structural context. Thus, by substitution of a gem-dimethyl group with an oxetane, aqueous solubility may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degradation in most cases. The incorporation of an oxetane into an aliphatic chain can cause conformational changes favoring synclinal rather than antiplanar arrangements of the chain. Additionally spirocyclic oxetanes (e.g., 2-oxa-6-aza-spiro[3.3]heptane) bear remarkable analogies to commonly used fragments in drug discovery, such as morpholine, and are even able to supplant the latter in its solubilizing ability. A rich chemistry of oxetan-3-one and derived Michael acceptors provide venues for the preparation of a broad variety of novel oxetanes not previously documented, thus providing the foundation for their broad use in chemistry and drug discovery.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oxetanes as versatile elements in drug discovery and synthesis.

              Sizable resources, both financial and human, are invested each year in the development of new pharmaceutical agents. However, despite improved techniques, the new compounds often encounter difficulties in satisfying and overcoming the numerous physicochemical and many pharmacological constraints and hurdles. Oxetanes have been shown to improve key properties when grafted onto molecular scaffolds. Of particular interest are oxetanes that are substituted only in the 3-position, since such units remain achiral and their introduction into a molecular scaffold does not create a new stereocenter. This Minireview gives an overview of the recent advances made in the preparation and use of 3-substituted oxetanes. It also includes a discussion of the site-dependent modifications of various physicochemical and biochemical properties that result from the incorporation of the oxetane unit in molecular architectures.
                Bookmark

                Author and article information

                Journal
                Org Lett
                Org Lett
                ol
                orlef7
                Organic Letters
                American Chemical Society
                1523-7060
                1523-7052
                21 March 2022
                01 April 2022
                : 24
                : 12
                : 2365-2370
                Affiliations
                []Department of Chemistry, Imperial College London, Molecular Sciences Research Hub , White City Campus, Wood Lane, London W12 0BZ, U.K.
                []Department of Biomolecular Sciences, School of Pharmacy, University of Urbino “Carlo Bo” , P.za Rinascimento, 6, 61029 Urbino (PU), Italy
                [§ ]Pfizer Worldwide Research, Development and Medical , Eastern Point Road, Groton, Connecticut 06340, United States
                Author notes
                Author information
                https://orcid.org/0000-0002-9471-5888
                https://orcid.org/0000-0003-3459-3767
                https://orcid.org/0000-0003-3993-5818
                Article
                10.1021/acs.orglett.2c00568
                9007565
                35311271
                6b27e0ee-4f40-4ad1-ab61-84a9ad168fb5
                © 2022 American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 21 February 2022
                Categories
                Letter
                Custom metadata
                ol2c00568
                ol2c00568

                Organic & Biomolecular chemistry
                Organic & Biomolecular chemistry

                Comments

                Comment on this article